Physiochemical Activity|N0000000065|
Epidermal Growth Factor Receptor Interactions|N0000000067|
Angiotensin Receptor Antagonists|N0000000070|
Macrophage Colony Stimulating Factor Receptor Interactions|N0000000081|
Cholinergic Muscarinic Antagonists|N0000000125|
5-alpha Reductase Inhibitors|N0000000126|
HIV Integrase Inhibitors|N0000000127|
Phosphodiesterase Inhibitors|N0000000128|
Lipoproteins|N0000000129|
Serotonin Antagonists|N0000000130|
Prostaglandin Receptor Interactions|N0000000131|
Organic Anion Transporter Interactions|N0000000132|
Adrenergic alpha-Antagonists|N0000000099|
Prostaglandin Receptor Antagonists|N0000000108|
Serotonin Uptake Inhibitors|N0000000109|
Glucocorticoid Receptor Antagonists|N0000000110|
Folic Acid Antagonists|N0000000111|
Histamine Agonists|N0000000112|
Enzymatic Receptor Interactions|N0000000113|
Dopamine Uptake Inhibitors|N0000000114|
Progestational Hormone Receptor Antagonists|N0000000115|
GABA B Agonists|N0000000116|
Enzyme Inhibitors|N0000000133|
Lipoxygenase Inhibitors|N0000000134|
Adjuvants, Immunologic|N0000000135|
Parathormone Receptor Antagonists|N0000000136|
IGF Type 1 Receptor Interactions|N0000000137|
GABA A Receptor Interactions|N0000000138|
Mineralocorticoid Receptor Antagonists|N0000000139|
Calcium Channel Interactions|N0000000140|
Pituitary Hormones Receptor Interactions|N0000000141|
Biological Macromolecular Agents|N0000000142|
Cholinergic Nicotinic Agonists|N0000000143|
Iron Chelating Activity|N0000000144|
Estrogen Receptor Antagonists|N0000000145|
Androgen Receptor Agonists|N0000000146|
Proton Pump Inhibitors|N0000000147|
Receptor-Effector Coupled System Interactions|N0000000148|
Hormone Receptor Agonists|N0000000149|
Protein Synthesis Inhibitors|N0000000150|
Histamine H2 Antagonists|N0000000151|
G-Protein-linked Receptor-Effector Interactions|N0000000152|
Adrenergic Receptor Interactions|N0000000153|
Opioid Antagonists|N0000000154|
Uncouplers|N0000000155|
Chloride Channel Interactions|N0000000156|
Interferon Inducers|N0000000157|
Parathormone Receptor Agonists|N0000000158|
Glucocorticoid Receptor Agonists|N0000000159|
Cyclooxygenase Inhibitors|N0000000160|
Adrenergic beta-Antagonists|N0000000161|
Steroid Receptor Antagonists|N0000000162|
Enzyme Interactions|N0000000163|
Vitamin K Epoxide Reductase Inhibitors|N0000000164|
Pituitary Hormone Receptor Agonists|N0000000165|
alpha Glucosidase Inhibitors|N0000000166|
Serotonin Transporter Interactions|N0000000167|
Selective Estrogen Receptor Modulators|N0000000168|
Serine Proteinase Inhibitors|N0000000169|
Free Radical Scavengers|N0000000170|
Excitatory Amino Acid Receptor Interactions|N0000000171|
Steroid Receptor Modulators|N0000000172|
Nitric Oxide Synthase Inhibitors|N0000000173|
Opioid Agonists|N0000000174|
Cytokine Receptor Superfamily Interactions|N0000000175|
Topoisomerase Inhibitors|N0000000176|
Cholinesterase Inhibitors|N0000000177|
Enzymatic Agents|N0000000178|
Alcohol Dehyrogenase Inhibitors|N0000000179|
Sodium Channel Interactions|N0000000180|
Angiotensin-Converting Enzyme Inhibitors|N0000000181|
Steroid Hormone Receptor Agonists|N0000000182|
Acetyl Aldehyde Dehydrogenase Inhibitors|N0000000183|
Monoamine Oxidase Inhibitors|N0000000184|
Progestational Hormone Receptor Agonists|N0000000185|
Estrogen Receptor Modulators|N0000000186|
Adenosine Deaminase Inhibitors|N0000000187|
Serotonin 5HT-3 Agonists|N0000000188|
Platelet-Derived-Growth Factor beta Receptor Interactions|N0000000189|
Histamine H1 Antagonists|N0000000190|
Dihydrofolate Reductase Inhibitors|N0000000191|
Complement Inactivators|N0000000192|
Ion Channel Interactions|N0000000193|
Somatostatin Receptor Agonists|N0000000194|
Enkephalinase Inhibitors|N0000000195|
GABA A Agonists|N0000000196|
Trypsin Inhibitors|N0000000197|
Serotonin Receptor Interactions|N0000000198|
Cholinergic Nicotinic Interactions|N0000000199|
Opioid Receptor Interactions|N0000000200|
Bile Acids|N0000000201|
beta Lactamase Inhibitors|N0000000202|
Dopamine Receptor Interactions|N0000000203|
GABA B Receptor Interactions|N0000000204|
Radiopharmaceuticals|N0000000205|
Xanthine Oxidase Inhibitors|N0000000206|
Histamine Antagonists|N0000000207|
Enzyme Reactivators|N0000000208|
Adrenergic alpha-Agonists|N0000000209|
Binding Resins|N0000000210|
Potassium Channel Interactions|N0000000211|
Ribonucleotide Reductase Inhibitors|N0000000212|
Receptor Protein Kinase Interactions|N0000000213|
Sex Hormone Receptor Agonists|N0000000214|
ATP-Binding Cassette (ABC) Transporter Interactions|N0000000215|
Histamine Receptor Interactions|N0000000216|
Somatotropin Receptor Agonists|N0000000217|
Somatostatin Receptor Interactions|N0000000218|
Dopamine Transporter Interactions|N0000000219|
Electrolyte Preparations|N0000000220|
Hormone Receptor Antagonists|N0000000221|
Thyroid Hormone Receptor Antagonists|N0000000222|
Cellular or Molecular Interactions|N0000000223|
Chloride Channel Antagonists|N0000000224|
Insulin Receptor Agonists|N0000000225|
Acid-Base Preparations|N0000000226|
Cholinergic Nicotinic Antagonists|N0000000227|
Structural Macromolecules|N0000000228|
GABA B Antagonists|N0000000229|
Dopamine Antagonists|N0000000230|
Enzyme Activators|N0000000231|
Excitatory Amino Acid Agonists|N0000000232|
Nucleic Acid Synthesis Inhibitors|N0000000233|
Norepinephrine Transporter Interactions|N0000000234|
Carbonic Anhydrase Inhibitors|N0000000235|
Alkylating Activity|N0000000236|
Thyroid Hormone Receptor Agonists|N0000000237|
Na-K ATPases Interactions|N0000000238|
P-Glycoprotein Interactions|N0000000239|
Insulin Receptor Interactions|N0000000240|
Tissue Plasminogen Activators|N0000000241|
Transcription Factor Activity|N0000000242|
Androgen Receptor Antagonists|N0000000243|
Glycine Receptor Interactions|N0000000244|
Adrenergic beta-Agonists|N0000000245|
HIV Protease Inhibitors|N0000000246|
Biological Response Modifiers|N0000000247|
Non-receptor Tyrosine Kinase Inhibitors|N0000000248|
Pituitary Hormone Receptor Antagonists|N0000000249|
Melatonin Receptor Agonists|N0000000250|
GABA B Modulators|N0000000251|
GTP Phosphohydrolase Activators|N0000000252|
Polycationic Channel Interactions|N0000000253|
Immunologic and Biological Factors|N0000000254|
Hormone Receptor Modulators|N0000000255|
Serotonin Agonists|N0000000256|
Hormone Receptor Interactions|N0000000257|
Integrase Inhibitors|N0000000258|
Calcium Channel Agonists|N0000000259|
COX-2 Inhibitors|N0000008288|
Unknown Cellular or Molecular Interaction|N0000009915|
Lipase Inhibitors|N0000009916|
Adrenergic alpha1-Agonists|N0000009917|
Adrenergic alpha2-Agonists|N0000009918|
Adrenergic alpha1-Antagonists|N0000009919|
Adrenergic alpha2-Antagonists|N0000009920|
Adrenergic beta1-Agonists|N0000009921|
Adrenergic beta2-Agonists|N0000009922|
Adrenergic beta1-Antagonists|N0000009923|
Adrenergic beta2-Antagonists|N0000009924|
Antidiuretic Hormone Antagonist|N0000009945|
Para-Aminobenzoic Acid Inhibitor|N0000009946|
Nucleoside Reverse Transcriptase Inhibitors|N0000009947|
Non-Nucleoside Reverse Transcriptase Inhibitors|N0000009948|
Antibody Receptor Interactions|N0000009949|
Tumor Necrosis Factor Receptor Interactions|N0000009950|
Tumor Necrosis Factor Alpha Receptor Interactions|N0000009951|
Tumor Necrosis Factor Beta Receptor Interactions|N0000009952|
Tyrosine Kinase Inhibitors|N0000020001|
DNA Methytransferase Inhibitors|N0000019995|
Epidermal Growth Factor Inhibitor|N0000020006|
HER-2/Neu/cerbB2 Inhibitor|N0000020008|
HER-1 Inhibitor|N0000020010|
HER-3 Inhibitor|N0000020012|
NMDA Receptor Antagonist|N0000020015|
L-Calcium Channel Receptor Antagonist|N0000020065|
T-Calcium Channel Receptor Antagonist|N0000020066|
Voltage-gated Calcium Channel Receptor Antagonist|N0000020067|
Prostacyclin Receptor Agonists|N0000020068|
N-Calcium Channel Receptor Antagonist|N0000020069|
Keratinocyte Growth Factor Receptor Interactions|N0000020070|
Keratinocyte Growth Factor Receptor Agonist|N0000020071|
Keratinocyte Growth Factor Receptor Antagonist|N0000020072|
Ubiquitin Ligase  Inhibitors|N0000020084|
E3 Ubiquitin Ligase Inhibitor|N0000020085|
DNA Gyrase Inhibitors|N0000020086|
Topoisomerase 4 Inhibitors|N0000020087|
Topoisomerase 2 Inhibitors|N0000020088|
Viral Envelope Interaction|N0000020089|
Phosphate Chelating Activity|N0000020074|
Copper Chelating Activity|N0000020075|
Plutonium Chelating Activity|N0000020076|
Secretin Receptor Interactions|N0000020077|
Secretin Receptor Agonists|N0000020078|
Secretin Receptor Antagonists|N0000020079|
Calcium-Sensing Receptor Interactions|N0000020080|
Increased Calcium-Sensing Receptor Sensitivity|N0000020081|
Decreased Calcium-Sensing Receptor Sensitivity|N0000020082|
Hyaluronidase|N0000020050|
Glucagon-like Peptide-1 (GLP-1) Receptor Interactions|N0000020057|
Glucagon-like Peptide-1 (GLP-1) Agonist|N0000020058|
Glucagon-like Peptide-1 (GLP-1) Antagonist|N0000020059|
DNA Polymerase Inhibitors|N0000020060|
Receptor Activity Modifying Proteins|N0000020061|
Receptor Activity Modifying Protein Agonist|N0000020062|
Receptor Activity Modifying Proteins Antagonist|N0000020063|
Amylin Agonist|N0000020064|
PDGFR? Inhibitors|N0000020029|
PDGFR Inhibitors|N0000020030|
VEGFR1 Inhibitors|N0000020031|
VEGFR2 Inhibitors|N0000020032|
VEGFR3 Inhibitors|N0000020033|
Stem Cell Factor (KIT) Inhibitors|N0000020034|
Fms-like tyrosine kinase (FLT) Inhibitors|N0000020035|
Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors|N0000020036|
Neurotrophic Factor Receptor (RET) Inhibitors|N0000020037|
Sulfatases|N0000020038|
N-acetylgalactosamine 4-sulfatase|N0000020039|
ADH Receptor Antagonist|N0000020044|
BRAF Tyrosine Kinase Inhibitors|N0000020045|
Proteins|N0000020046|
Recombinant human insulin growth factor-1 ( rhIGF-1)|N0000020047|
Recombinant human insulin growth factor binding protein-3 (rhIGFBP-3)|N0000020048|
Hyaluronate Lyases|N0000020049|
Kainate Receptor Antagonist|N0000020017|
Glucosyl Transferase Inhibitors|N0000020018|
Glucosylceramide Synthase Inhibitors|N0000020019|
Antibody Surface Protein Interactions|N0000020023|
Sclerosing Agent|N0000020024|
14-alpha demethylase Inhibitors|N0000020025|
Phosphodiesterase 5 Inhibitors|N0000020026|
Glucan Synthase Inhibitors|N0000020027|
PDGFR? Inhibitors|N0000020029|
AMPA Receptor Antagonist|N0000020016|
Ionotropic Glutamate Receptor Antagonist|N0000020014|
HER Inhibitor|N0000020011|
Bcr-Abl Tyrosine Kinase Inhibitor|N0000020009|
Vascular Endothelial Growth Factor Inhibitor|N0000020007|
Receptor Tyrosine Kinase Inhibitors|N0000020000|
Hypothalamic Hormone Receptor Antagonist|N0000019994|
Hypothalamic Hormone Receptor Agonist|N0000019993|
Hypothalmic Hormone Interactions|N0000019992|
Insulin Receptor Antagonists|N0000000071|
Synaptic Fusion Complex Interactions|N0000009953|
Cell Membrane Fusion Complex Interactions|N0000009954|
Acetylcholine Transporter Interactions|N0000009955|
Sterol Synthesis Inhibitors|N0000009956|
Ergosterol Synthesis Inhibitors|N0000009957|
Bone Surface Interaction|N0000009958|
Dephosphorylation Inhibitors|N0000009959|
Antithrombin Activators|N0000009960|
Platelet Activating Factor Inhibitors|N0000009961|
Platelet Glycoprotein IIb/IIIA Inhibitors|N0000009962|
Thrombin Inhibitors|N0000009963|
Sulfate Donor|N0000009983|
hydrogen ion scavenger|N0000009986|
Nucleoside Receptor Interactions|N0000009987|
Transpepsidase Inhibitors|N0000010215|
Photoabsorbtion|N0000010217|
Absorbs Ultraviolet A Radiation|N0000010218|
Absorbs Ultraviolet B Radiation|N0000010219|
Antibody Target Interactions|N0000010226|
Antibody Antigen Interactions|N0000010227|
Cellular Structure Molecule Interactions|N0000010255|
Tubulin Interaction|N0000010256|
Imaging Contrast Agents|N0000010257|
X-Ray Contrast Agent|N0000010258|
Ultrasound Contrast Agent|N0000010259|
beta Tubulin Interaction|N0000010260|
Neurokinin 1 Receptor Interactions|N0000010261|
Neurokinin 1 Antagonist|N0000010262|
Tissue Plasminogen Activator Inhibitors|N0000010263|
Plasmin Inhibitors|N0000010264|
Squalene Monooxygenase Inhibitors|N0000010265|
Growth Hormone Receptor Agonists|N0000010266|
Growth Hormone Receptor Antagonists|N0000010267|
Amylase Inhibitors|N0000010274|
Glucagon Receptor Interaction|N0000010275|
Thyroid Peroxidase Inhibitors|N0000010276|
Interleukin 2 Receptor Interactions|N0000010278|
Interleukin 2 Receptor Inhibitors|N0000010279|
Interleukin 2 Receptor Activators|N0000010280|
CD3 Receptor Interactions|N0000010281|
Osmotic Agent|N0000010288|
Adenosine Diphosphate Receptor Inhibitors|N0000010334|
Hydrolases|N0000000091|
Adrenergic Antagonists|N0000000092|
Platelet-Derived Growth Factor alpha Receptor Interactions|N0000000093|
Mineralocorticoid Receptor Agonists|N0000000094|
Serotonin 5HT-3 Receptor Interactions|N0000000095|
Pancrelipases|N0000000096|
Cholinergic Muscarinic Receptor Interactions|N0000000097|
Thymidylate Synthetase Inhibitors|N0000000098|
Dopamine Agonists|N0000000117|
GABA A Modulators|N0000000118|
Glycine Antagonists|N0000000119|
Nitric Oxide Donors|N0000000120|
Hydroxymethylglutaryl-CoA Reductase Inhibitors|N0000000121|
Adrenergic Agonists|N0000000122|
Melatonin Receptor Interactions|N0000000123|
Leukotriene Receptor Interactions|N0000000124|
Estrogen Receptor Agonists|N0000000100|
Cysteine Proteinase Inhibitors|N0000000101|
Norepinephrine Uptake Inhibitors|N0000000102|
Reverse Transcriptase Inhibitors|N0000000103|
Cholinergic Muscarinic Agonists|N0000000104|
Neurotransmitter Transporter Interactions|N0000000105|
Prostaglandin Receptor Agonists|N0000000106|
Serotonin 5HT-3 Antagonists|N0000000090|
Glycine Agonists|N0000000073|
GABA A Antagonists|N0000000074|
GI Bulking Agents|N0000000075|
Protease Inhibitors|N0000000076|
Somatotropin Receptor Interactions|N0000000077|
Chloride Channel Agonists|N0000000078|
Surfactants|N0000000079|
Cholinesterase Reactivators|N0000000080|
Antithrombins|N0000000107|
Immunologic Factors|N0000000082|
Leukotriene Receptor Antagonists|N0000000083|
Sex Hormone Receptor Antagonists|N0000000084|
Receptor Interactions|N0000000085|
Complement 1 Inactivators|N0000000086|
Chelating Activity|N0000000087|
Excitatory Amino Acid Antagonists|N0000000088|
Plasminogen Activators|N0000000089|
Active Transporter Interactions|N0000000072|
Small Ion Transport Pump Interactions|N0000000066|
Calcium Channel Antagonists|N0000000069|
Parathormone Receptor Interactions|N0000000068|